Alpha-1 Video for Physicians

A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1-Antitrypsin Deficiency

Presentation by David H. Perlmutter, MD, before the The Liver Meeting 2013 of the American Association for the Study of Liver Diseases.

Return to to the main study page.